Dare Bioscience (DARE) Non Operating Income (2014 - 2017)
Dare Bioscience's (DARE) quarterly Non Operating Income came in at -$110000.0 in Q2 2017, up 80.5% YoY from -$60943.0 in Q2 2016, and up 86.13% on a QoQ basis from -$793000.0 in Q1 2017.
Dare Bioscience (DARE) Non Operating Income (2014 - 2017) Analysis & Trends
Dare Bioscience (DARE) has 4 years of Non Operating Income data on file, last reported at -$110000.0 in Q2 2017.
- Quarterly Non Operating Income rose 80.5% year-over-year to -$110000.0 in Q2 2017, while the trailing twelve-month figure through Jun 2017 was -$1.8 million (up 23.82% YoY) and the FY2016 annual result came in at -$2.2 million, up 11.19% from the prior year.
- Non Operating Income rose to -$110000.0 in Q2 2017, from -$793000.0 in the prior quarter.
- In the past five years, Non Operating Income ranged from a high of $44000.0 in Q1 2014 to a low of -$2.8 million in Q2 2014.
- A 4-year average of -$609928.6 and a median of -$508500.0 in 2015 frame the typical range for Non Operating Income.
- The widest YoY moves for Non Operating Income: up 81.44% in 2015, down 1731.82% in 2015.
- Tracing DARE's Non Operating Income over 4 years: stood at -$159000.0 in 2014, then tumbled by 332.08% to -$687000.0 in 2015, then soared by 36.39% to -$437000.0 in 2016, then surged by 74.83% to -$110000.0 in 2017.
- The last three Non Operating Income figures came in at -$110000.0 (Q2 2017), -$793000.0 (Q1 2017), and -$437000.0 (Q4 2016), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 234.30 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -53.64 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | -51.63 Mn |
| 10 | Dare Bioscience | 12.36 Mn | -256,055.23 | -132,343.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2017 | -110,000.00 |
| Mar 31, 2017 | -793,000.00 |
| Dec 31, 2016 | -437,000.00 |
| Sep 30, 2016 | -496,000.00 |
| Jun 30, 2016 | -564,000.00 |
| Mar 31, 2016 | -654,000.00 |
| Dec 31, 2015 | -687,000.00 |
| Sep 30, 2015 | -505,000.00 |
| Jun 30, 2015 | -512,000.00 |
| Mar 31, 2015 | -718,000.00 |
| Dec 31, 2014 | -159,000.00 |
| Sep 30, 2014 | -189,000.00 |
| Jun 30, 2014 | -2.76 Mn |
| Mar 31, 2014 | 44,000.00 |